TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Orifarm Generics A/S
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
314,075
|
286,859
|
279,014 |
| Earnings before taxes |
10,327
|
10,769
|
9,351 |
| Total assets |
139,448
|
185,486
|
180,894 |
| Current assets |
131,770
|
178,748
|
174,530 |
| Current liabilities |
63,418
|
117,660
|
121,435 |
| Equity capital |
74,331
|
66,370
|
58,056 |
| - share capital |
134
|
134
|
134 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
53.3%
|
35.8%
|
32.1% |
| Turnover per employee |
2,094
|
1,912
|
1,860 |
| Profit as a percentage of turnover |
3.3%
|
3.8%
|
3.4% |
| Return on assets (ROA) | |||
| Current ratio |
207.8%
|
151.9%
|
143.7% |
| Return on equity (ROE) |
13.9%
|
16.2%
|
16.1% |
| Change turnover |
27,490
|
8,466
|
42,694 |
| Change turnover % |
10%
|
3%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.